Acquired pure red cell aplasia in a hemodialyzed patient

International Journal of Urology

Volumn 10, Issue 10, 2003, Pages 550-553

  Tanuma, Yasushi ^a   Yokoo, Akifumi ^a   Takashima, Hidenori ^a  

^a KAWASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Hemodialysis; Pure red cell aplasia; Recombinant human erythropoietin

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; ERYTHROBLASTOPENIA; ERYTHROCYTE APLASIA; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MALE; PRIORITY JOURNAL;

AGED; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MALE; RED-CELL APLASIA, PURE; RENAL DIALYSIS;

EID: 0242720921     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2003.00672.x     Document Type: Article

References (14)

1. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythiopoietin outside the setting of uremia. Blood 1997; 89: 4248-67.
2. Drücke T. R-HuEpo hyporesponsiveness - who and why. Nephrol. Dial. Transplant. 1995; 10 (Suppl. 2): 62-8.
3. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br. J. Haematol. 2000; 111: 1010-22.
4. Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur. J. Haematol. 1997; 59: 199-205.
5. Casadevall N, Nataf J, Viron B et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl. J. Med. 2002; 346: 469-75.
6. Drücke TB. Modulating factors in the hematopoietic response to erythropoietin. Am. J. Kidney Dis. 1991; 18 (Suppl. 1): 87-92.
7. Larroche C, Mouthon L, Casadevall N, Roux GL, Casassus P, Guillevin L. Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins. Eur. J. Haematol. 2000; 65: 74-6.
8. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin. Transplant. 2000; 14: 586-91.
9. Tzioufas AG, Kokori SI, Petrovas CI, Moutsopoulos HM. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 2212-6.
10. Krantz SB. Pure red cell aplasia. N. Engl. J. Med. 1974; 291: 345-50.
11. Clark DA, Dessypris EN, Krantz SB. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 1984; 63: 277-86.
12. Faulds D, Goa KL, Benfield P. Cyclosporin: a review of its pharmacodynamic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993; 45: 953.
13. Nakamura T, Hiraki Y, Fukushima K, Masada M, Ueda T. The effective blood level of Cyclosporine A for a pure red cell aplasia patient. Jpn. J. Clin. Pharmacol. Ther. 1998; 29: 805-8.
14. Okada H, Suzuki H, Uchida H et al. Acquired idiopathic pure red cell aplasia in a hemodialyzed patient with inactive systemic lupus erythematosus. Intern. Med. 1994; 33: 492-5.